Just Released: "Spain Pharmaceuticals & Healthcare Report Q3 2013"
The deterioration of the Spanish economy and the government's implementation of increasingly aggressive fiscal austerity policies that focus on cost containment in the healthcare sector will lead to yearly declines in pharmaceutical spending, at least until 2017. Our view is supported by the success of previous government measures, including the steep decline in state spending on medicines and the drop in average expenditure per prescription following the implementation of Royal Decree Laws 4 and 8/2010, Royal Decree Law 9/2011 and...
View full press release